CytRx Corp (CYTR.OQ)
1.08USD
5:14pm BST
$0.01 (+0.93%)
$1.07
$1.08
$1.08
$1.05
6,617
29,321
$3.65
$1.05
About
Overall
| Beta: | 1.88 |
| Market Cap(Mil.): | $37.00 |
| Shares Outstanding(Mil.): | 33.64 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CYTR.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 98.72 | 30.39 |
| EPS (TTM): | -0.60 | -- | -- |
| ROI: | -55.35 | 0.92 | 12.61 |
| ROE: | -75.05 | -0.89 | 14.80 |
BRIEF-CytRx Announces Closing Of $7.0 Mln Registered Direct Offering
* CYTRX ANNOUNCES CLOSING OF $7.0 MILLION REGISTERED DIRECT OFFERING Source text for Eikon: Further company coverage:
BRIEF-Cytrx Announces $7.0 Million Registered Direct Offering
* CYTRX - ENTERED PURCHASE AGREEMENTS WITH CERTAIN INSTITUTIONAL INVESTORS TO SELL IN REGISTERED DIRECT OFFERING 5.6 MILLION SHARES AT PRICE OF $1.25/SHARE Source text for Eikon: Further company coverage:
BRIEF-Cytrx Reports First Quarter Loss Of $0.15 Per Share
* CASH AND CASH EQUIVALENTS OF $35.1 MILLION AS OF MARCH 31, 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
BRIEF-Cytrx Presents Statistically Significant Breakthrough Data For Its Albumin Binding Ultra High Potency Ladr Drug Candidates
* CYTRX PRESENTS STATISTICALLY SIGNIFICANT BREAKTHROUGH DATA FOR ITS ALBUMIN BINDING ULTRA HIGH POTENCY LADR DRUG CANDIDATES
BRIEF-CytRx Selects Four New LADR™ Ultra High Potency Drug Candidates For Advancement Toward Clinical Trials
* CYTRX SELECTS FOUR NEW LADR™ ULTRA HIGH POTENCY DRUG CANDIDATES FOR ADVANCEMENT TOWARD CLINICAL TRIALS
BRIEF-Cytrx Corp Announces Its Entry Into A Definitive Agreement With Destum Partners
* CYTRX CORP - ANNOUNCED ITS ENTRY INTO A DEFINITIVE AGREEMENT WITH DESTUM PARTNERS
Competitors
| Price | Chg | |
|---|---|---|
| Sanofi India Ltd (SANO.NS) | Rs6,114.65 | -66.30 |
| Aeolus Pharmaceuticals, Inc. (AOLS.PK) | $0.00 | 0.00 |
| Mitsubishi Tanabe Pharma Corp (4508.T) | ¥1,897 | -22.00 |
| ONO PHARMACEUTICAL CO., LTD. (4528.T) | ¥2,820 | -19.50 |
| Oxford BioMedica plc (OXB.L) | 886.40 | +31.70 |
| IXICO PLC (IXI.L) | 35.00 | +3.00 |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 9,250.00 | +38.00 |
| Amgen, Inc. (AMGN.OQ) | $197.89 | +0.33 |
| Biogen Inc (BIIB.OQ) | $346.15 | +2.04 |
| Cephalon, Inc. (CEPH.OQ) | -- | -- |
Estimates